Guilherme Campos Shares Expertise on Greater Bay Area and Hainan’s Potential for Italian Companies
Guilherme Campos, International Business Advisory Manager for South China at Dezan Shira & Associates, was recently invited to speak at the “China’s Greater Bay Area & Hainan – Opportunities for Italian Companies” event. The event was hosted by the China-Italy Chamber of Commerce (CICC) at the China International Consumer Products Expo 2023 in Haikou. Guilherme shared his expert knowledge of GBA and Hainan’s potential for Italian companies. He elaborated on industry profiles and tax incentives in both regions and took a deep dive into the benefits the RCEP brings for GBA and Hainan.
“RCEP offers significant benefits. The agreement will promote the free flow of goods, services, and investment across the region, reducing trade barriers and boosting economic growth. With reduced tariffs, Chinese companies operating in the GBA and Hainan can access new markets and expand their customer base. Moreover, the agreement provides a framework for cooperation in areas such as intellectual property and e-commerce, which are crucial for the development of the digital economy,” said Guilherme.
About Dezan Shira & Associates’ Presence in South China
Dezan Shira & Associates was founded in Hong Kong in 1992 and has since expanded to 29 offices across Asia. The company has established a robust presence in China’s Greater Bay Area, boasting offices in several Guangdong Province cities, including Guangzhou, Shenzhen, Zhongshan, and Dongguan. Dezan Shira & Associates will soon open up its Hainan branch, which will provide clients and partners with even more local benefits. The expansion will enable the company to further support foreign businesses looking to enter the Chinese market, particularly those seeking to streamline production and supply chains.
- Investing in China’s Greater Bay Area: Tapping into Long-Term Opportunities
- A Different Hainan, Your New Partner: Emerging Opportunities at Hainan Free Trade Port
- Hainan Province in China Allows Import of Urgently Needed Drugs and Medical Devices from May 1